Business
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET LITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:
About this update from Precision Optics Corporation, Inc.
[{"type":"text","content":"Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET\nLITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its third quarter fiscal year 2026 for the period ended March 31, 2026. Q3 2026 Financial Highlights (3 Months Ended March 31, 2026): Revenue was $8.7 million, a quarterly record, compared to $4.2 million in the same quarter of the previous fiscal year, representing growth of approximately 108%, and compared to $7.4 million in the most recent sequential quarter.Production revenue, or total revenue net of engineering revenue, was $7.6 million, a quarterly record, compared to $3.3 million in the same quarter of the previous fiscal year, representing growth of approximately 131%, and compared to $6.4 million in the most recent sequential quarter.Engineering revenue was $1.1 million compared to $0.9 million in the same quarter of the previous fiscal year, an increase of 22%, and compared to $1.0 million in the most recent sequential quarter.Gross margins were 23.6% compared to 10.0% in the same quarter of the previous fiscal year and compared to 2.8% in the most recent sequential quarter.Net loss for the quarter was $(0.1) million, compared to $(2.1) million in the same quarter of the previous fiscal year, and compared to $(1.8) million in the most recent sequential quarter.Adjusted EBITDA was $0.3 million for the quarter compared to $(1.3) million in the same quarter of the previous fiscal year and compared to $(1.5) million in the most recent sequential quarter. Recent Additional Highlights: Increased production to a top-tier aerospace company. Third quarter fiscal 2026 revenue totaled $3.6 million from this customer, a quarterly revenue record.Increased production of cystoscopy surgery system. Third quarter fiscal 2026 revenue totaled $2.2 million from this customer, a quarterly revenue record.Received a $3.5 million follow-on production order for single-use ophthalmic program, with shipments expected to commence during the fourth fiscal quarter.The Company’s Ross Optical operations saw continued strong volume growth, driving a 65% year-over-year growth in the segment’s revenues.Completed an overs...